These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8169397)

  • 1. The role of tumor necrosis factor-alpha in acute murine cytomegalovirus infection in BALB/c mice.
    Shanley JD; Goff E; Debs RJ; Forman SJ
    J Infect Dis; 1994 May; 169(5):1088-91. PubMed ID: 8169397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.
    Yerkovich ST; Olver SD; Lenzo JC; Peacock CD; Price P
    Immunology; 1997 May; 91(1):45-52. PubMed ID: 9203964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.
    Cook CH; Trgovcich J; Zimmerman PD; Zhang Y; Sedmak DD
    J Virol; 2006 Sep; 80(18):9151-8. PubMed ID: 16940526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis.
    Zhou J; Zhang M; Atherton SS
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1691-700. PubMed ID: 17389501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.
    Lenzo JC; Fairweather D; Shellam GR; Lawson CM
    Cell Immunol; 2001 Oct; 213(1):52-61. PubMed ID: 11747356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.
    Pavić I; Polić B; Crnković I; Lucin P; Jonjić S; Koszinowski UH
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2215-23. PubMed ID: 8105025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis.
    Ritter JT; Tang-Feldman YJ; Lochhead GR; Estrada M; Lochhead S; Yu C; Ashton-Sager A; Tuteja D; Leutenegger C; Pomeroy C
    Cardiovasc Pathol; 2010; 19(2):83-93. PubMed ID: 19217318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumor necrosis factor-alpha treatment on mortality in murine cytomegalovirus-infected mice.
    Anderson KP; Lie YS; Low MA; Fennie EH
    Antiviral Res; 1993 Aug; 21(4):343-55. PubMed ID: 8215304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.
    Farrell HE; Shellam GR
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():149-56. PubMed ID: 1846643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment.
    Fennie EH; Lie YS; Low MA; Gribling P; Anderson KP
    Antiviral Res; 1988 Nov; 10(1-3):27-39. PubMed ID: 2852918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the effects of murine cytomegalovirus on the pancreas.
    Price P; Baxter AG; Allcock RN; Papadimitriou JM
    Eur J Clin Invest; 1998 Jul; 28(7):546-53. PubMed ID: 9726035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.
    Shanley JD; Pesanti EL
    J Infect Dis; 1985 Mar; 151(3):454-8. PubMed ID: 2982963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
    Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
    J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute murine cytomegalovirus infection induces lethal hepatitis.
    Shanley JD; Biczak L; Forman SJ
    J Infect Dis; 1993 Feb; 167(2):264-9. PubMed ID: 8380608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection.
    Leung WC; Hashimoto K; Umehara K; Hata J
    Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma.
    Dix RD; Cousins SW
    Curr Eye Res; 2004; 29(2-3):173-80. PubMed ID: 15512964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40.
    Carr JA; Rogerson JA; Mulqueen MJ; Roberts NA; Nash AA
    J Interferon Cytokine Res; 1999 Oct; 19(10):1145-52. PubMed ID: 10547154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L3T4+ lymphocyte depletion on acute murine cytomegalovirus infection.
    Erlich KS; Mills J; Shanley JD
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1765-71. PubMed ID: 2544664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.